|
1994, Volume 40, Issue 3 |
|
| 2-6 |
Dilakian E.A., Balaevskaia T.O., Zakamaldina-Tsama T.A., Topol L.Z., Solov'eva N.I.
Expression of cathepsins D and L during neoplastic transformation of fibroblasts
|
   |
| 6-8 |
Gureeva T.A., Golubeva N.V., Lubkova O.N., Lokshina L.A.
A comparative study of aspartyl and cysteine proteinases and their inhibitors in human B- and T-cell leukemias
|
|
| 9-11 |
Kugaevskaia E.V., Pavlikhina L.V., Eliseeva Yu.E.
Participation of serine proteinases in transforming the high molecular weight (600 kDa) form of angiotensin 1-converting enzyme into the low molecular weight form (190 kDa)
|
|
| 11-15 |
Dotsenko V.L., Neshkova E.A., Chebotar I.V., Chelyshev I.V., Maianskiĭ A.N., Iarovaia G.A.
Secretion of membrane-bound serine proteinases by polymorphonuclear leukocytes during adhesion to various types of receptor-dependent and receptor-independent sorbents
|
|
| 16-18 |
Iarovaia G.A., Korovina N.A., Magomedova M.P.
The kallikrein-kinin system and blood plasma proteolysis inhibitors in various childhood nephropathies
|
|
| 18-20 |
Sakharov I.Yu., Gliantsev S.P., Litvin F.E., Gordeev V.F.
Pharmacokinetic study of collagenase from the king crab, Paralithodes camtschatica
|
|
| 20-25 |
Dotsenko V.L., Neshkova E.A., Iarovaia G.A.
Detection of human leukocyte elastase from a plasma alpha-1-proteinase inhibitor complex by its enzymatic activity with a synthetic substrate
|
|
| 25-31 |
Larionova N.I., Balabushevich N.G., Gladysheva I.P., Moroz N.A., Kazanskaia N.F., Polekhina O.V., Donetskiĭ I.A.
Natural proteinase inhibitors as a basis for creating new drugs
|
|
| 31-35 |
Aĭsina R.B., Zhitkova Yu.V., Varfolomeev S.D.
Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro
|
|
| 35-37 |
Eliseeva Yu.E., Pavlikhina L.V., Shavgulidze T.V., Messina E., Dzhakonello A., Salerno K., Perrikone R.
An endogenous activator of angiotensin-converting enzyme
|
|
| 37-40 |
Kuznetsova T.P., Chesnokova N.B., Paskhina T.S.
Activity of tissue and plasma kallikrein and their precursor levels in rabbit tears after alkaline burns of the cornea
|
|
| 41-43 |
Kantsaliev A.L., Kushlinskii N.E., Vasil'ev A.V., Klimenkov A.A.
Proteolytic enzyme activity in stomach cancer patients with various prognoses
|
|
| 43-46 |
Andreenko G.V., Liutova L.V., Rudenskaia G.N., Karabasova M.A., Kupenko O.G., Isaev V.A.
Fibrinolytic and thrombolytic properties of the drug morikrase
|
|
| 46-48 |
Isaev V.A., Liutova L.V., Karabasova M.A., Kupenko O.G., Andreenko G.V., Rudenskaia G.N.
The wound healing effect of ointment with morikrase
|
|
| 48-51 |
Semenov V.V., Studentsova I.A., Durnev A.D., Seredenin S.B., Vizel A.O.
Antimutagens as modifiers of the cellular cyclase system
|
|
| 51-53 |
Pletsityĭ K.D., Davydova T.V., Fomina V.G.
The immunocorrecting effect of vitamin E during ethanol intoxication
|
|
| 53-56 |
Vasil'ev A.V., Biiasheva I.R., Pokrovskaia G.R., Mal'tsev G.Iu., Varsanovich E.A., Orlova L.A., Soto S.Kh.
The antioxidant defense system in hypertension patients on a diet enriched with omega 3 polyunsaturated fatty acids and alphalphalpha-tocopherol
|
|
| 57-58 |
Bureĭko A.S., Dorofeĭkov V.V., Shcherbak I.G.
Gas chromatographic method for determining esterase activity of proteolytic enzymes using continuous gas extraction of the volatile product
|
|